Senseonics Holdings, Inc. (SENS)
SENS Stock Price Chart
Explore Senseonics Holdings, Inc. interactive price chart. Choose custom timeframes to analyze SENS price movements and trends.
SENS Company Profile
Discover essential business fundamentals and corporate details for Senseonics Holdings, Inc. (SENS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
22 Dec 2015
Employees
117.00
Website
https://www.senseonics.comCEO
Timothy T. Goodnow
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
SENS Financial Timeline
Browse a chronological timeline of Senseonics Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 2 Mar 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.02, while revenue estimate is $7.81M.
Earnings released on 6 Aug 2025
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $8.30M , beating expectations by +37.78%.
Earnings released on 8 May 2025
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $6.26M , beating expectations by +12.59%.
Earnings released on 3 Mar 2025
EPS came in at -$0.02 surpassing the estimated -$0.03 by +33.33%, while revenue for the quarter reached $8.30M , beating expectations by +4.39%.
Earnings released on 7 Nov 2024
EPS came in at -$0.04 falling short of the estimated -$0.03 by -17.65%, while revenue for the quarter reached $4.26M , missing expectations by -45.26%.
Earnings released on 8 Aug 2024
EPS came in at -$0.03 falling short of the estimated -$0.03 by -2.42%, while revenue for the quarter reached $4.87M , missing expectations by -1.52%.
Earnings released on 13 May 2024
EPS came in at -$0.03 matching the estimated -$0.03, while revenue for the quarter reached $5.05M , beating expectations by +9.72%.
Earnings released on 29 Feb 2024
EPS came in at -$0.03 falling short of the estimated -$0.02 by -29.14%, while revenue for the quarter reached $8.03M , beating expectations by +7.35%.
Earnings released on 9 Nov 2023
EPS came in at -$0.04 falling short of the estimated -$0.04 by -14.29%, while revenue for the quarter reached $6.10M , missing expectations by -18.49%.
Earnings released on 10 Aug 2023
EPS came in at -$0.04 falling short of the estimated -$0.04 by -3.23%, while revenue for the quarter reached $4.13M , missing expectations by -8.11%.
Earnings released on 9 May 2023
EPS came in at -$0.03 falling short of the estimated -$0.03 by -20.00%, while revenue for the quarter reached $4.14M , beating expectations by +22.76%.
Earnings released on 15 Mar 2023
EPS came in at -$0.01 surpassing the estimated -$0.05 by +80.00%, while revenue for the quarter reached $5.57M , beating expectations by +2.79%.
Earnings released on 8 Nov 2022
EPS came in at -$0.13 falling short of the estimated -$0.04 by -205.88%, while revenue for the quarter reached $4.62M , beating expectations by +4.61%.
Earnings released on 9 Aug 2022
EPS came in at -$0.03 falling short of the estimated -$0.02 by -29.42%, while revenue for the quarter reached $3.71M , beating expectations by +4.82%.
Earnings released on 10 May 2022
EPS came in at -$0.03 falling short of the estimated -$0.03 by -14.29%, while revenue for the quarter reached $2.48M , beating expectations by +10.96%.
Earnings released on 1 Mar 2022
EPS came in at $0.01 surpassing the estimated $0.00 by +762.07%, while revenue for the quarter reached $4.01M , beating expectations by +0.78%.
Earnings released on 9 Nov 2021
EPS came in at -$0.03 surpassing the estimated -$0.07 by +57.14%, while revenue for the quarter reached $3.53M , beating expectations by +0.34%.
Earnings released on 9 Aug 2021
EPS came in at -$0.05 falling short of the estimated -$0.00 by -1.47K%, while revenue for the quarter reached $3.29M , beating expectations by +13.81%.
Earnings released on 13 May 2021
EPS came in at -$0.04 surpassing the estimated -$0.06 by +33.33%, while revenue for the quarter reached $2.85M , missing expectations by -90.42%.
Earnings released on 4 Mar 2021
EPS came in at -$0.12 falling short of the estimated -$0.11 by -9.09%, while revenue for the quarter reached $3.89M .
Earnings released on 9 Nov 2020
EPS came in at -$0.10 falling short of the estimated -$0.06 by -66.67%, while revenue for the quarter reached $767.00K , beating expectations by +21.21%.
SENS Stock Performance
Access detailed SENS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.